Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Capital Expenditures (2020 - 2022)

Historic Capital Expenditures for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q3 2022 value amounting to $20000.0.

  • Atea Pharmaceuticals' Capital Expenditures changed N/A to $20000.0 in Q3 2022 from the same period last year, while for Dec 2022 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2022, which is 4847500.0% up from last year.
  • Latest data reveals that Atea Pharmaceuticals reported Capital Expenditures of $20000.0 as of Q3 2022.
  • Over the past 5 years, Atea Pharmaceuticals' Capital Expenditures peaked at $1.2 million during Q2 2022, and registered a low of $5000.0 during Q4 2020.